Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Frasure-Smith

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Progress in Cardiovascular Nursing|March 6, 2009
AHA science advisory. Depression and coronary heart disease. Recommendations for screening, referral, and treatment. A science advisory from the American Heart Association Prevention Committee to the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care Outcomes Research. Endorsed by the American Psychiatric AssociationJudith H Lichtman, J Thomas Bigger, James A Blumenthal, et al.
JAMA|January 25, 2007
Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trialFrançois Lespérance, Nancy Frasure-Smith, Diana Koszycki, et al.
The Canadian Journal of Cardiology|July 28, 2011
Evaluation of resynchronization therapy for heart failure in patients with a QRS duration greater than 120 ms (GREATER-EARTH) trial: rationale, design, and baseline characteristicsBernard Thibault, François Harel, Anique Ducharme, et al.
Journal of the American College of Cardiology|July 21, 2004
Depression as a risk factor for post-MI mortalityRobert M Carney, Kenneth E Freedland, Allan S Jaffe, et al.
Circulation|November 23, 2011
Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex ≥120 millisecondsBernard Thibault, Anique Ducharme, François Harel, et al.
JAMA|November 13, 2008
Depression screening and patient outcomes in cardiovascular care: a systematic reviewBrett D Thombs, Peter de Jonge, James C Coyne, et al.
Circulation|February 26, 2014
Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart AssociationJudith H Lichtman, Erika S Froelicher, James A Blumenthal, et al.
Circulation|February 8, 2013
Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trialBernard Thibault, François Harel, Anique Ducharme, et al.
Contemporary Clinical Trials|May 30, 2012
Design and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trialWilliam Whang, Matthew M Burg, Robert M Carney, et al.
Psychosomatic Medicine|October 3, 2006
Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group ReportKarina W Davidson, David J Kupfer, J Thomas Bigger, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Progress in Cardiovascular Nursing|March 6, 2009
AHA science advisory. Depression and coronary heart disease. Recommendations for screening, referral, and treatment. A science advisory from the American Heart Association Prevention Committee to the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care Outcomes Research. Endorsed by the American Psychiatric AssociationJudith H Lichtman, J Thomas Bigger, James A Blumenthal, et al.
JAMA|January 25, 2007
Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trialFrançois Lespérance, Nancy Frasure-Smith, Diana Koszycki, et al.
The Canadian Journal of Cardiology|July 28, 2011
Evaluation of resynchronization therapy for heart failure in patients with a QRS duration greater than 120 ms (GREATER-EARTH) trial: rationale, design, and baseline characteristicsBernard Thibault, François Harel, Anique Ducharme, et al.
Journal of the American College of Cardiology|July 21, 2004
Depression as a risk factor for post-MI mortalityRobert M Carney, Kenneth E Freedland, Allan S Jaffe, et al.
Circulation|November 23, 2011
Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex ≥120 millisecondsBernard Thibault, Anique Ducharme, François Harel, et al.
JAMA|November 13, 2008
Depression screening and patient outcomes in cardiovascular care: a systematic reviewBrett D Thombs, Peter de Jonge, James C Coyne, et al.
Circulation|February 26, 2014
Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart AssociationJudith H Lichtman, Erika S Froelicher, James A Blumenthal, et al.
Circulation|February 8, 2013
Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trialBernard Thibault, François Harel, Anique Ducharme, et al.
Contemporary Clinical Trials|May 30, 2012
Design and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trialWilliam Whang, Matthew M Burg, Robert M Carney, et al.
Psychosomatic Medicine|October 3, 2006
Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group ReportKarina W Davidson, David J Kupfer, J Thomas Bigger, et al.
Pageof 7